Intellezy, an innovative learning solutions provider, has once again been recognized by Training Industry, earning a spot on its 2025 Online Learning Library Companies Watch List. This marks Intellezy's fourth consecutive year receiving this recognition, underscoring the company's ongoing commitment to delivering world-class training experiences for today's evolving workforce. https://mma.prnewswire.com/media/2574622/Intellezy_Logo.jpg Training Industry, the leading research […]

SAN FRANCISCO, CA / ACCESS Newswire / August 12, 2025 / National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS) who purchased or otherwise acquired Hims & Hers securities between April 29, 2025 and June 23, 2025, inclusive (the "Class Period")

(NASDAQ:BTAI), Topline data from SERENITY At-Home Phase 3 trial for acute treatment of agitation associated with bipolar disorders or schizophrenia expected in August FDA meeting scheduled in August and is intended to support potential sNDA submission for label expansion of IGALMI(R) in the at-home setting Publication of non-clinical data in Frontiers in Pharmacology suggests potential

Innovative Wealth Management Firm Ranked #8 on Inc. 5000 Fastest-Growing Private Companies in America, With Three-Year Revenue Growth of ~12,000% Farther, the intelligent wealth management firm fusing adaptive, proprietary technology with expert financial advisor guidance, today announced it has ranked #8 overall and #1 in financial services on the 2025 Inc. 5000 list of the

Revenue of $1.9 Million consistent with the year-ago period – Revenue led by Population Health's growth up 197% compared to Q2 2024 – Gross Margin increases to 38.7%, up 2,090 basis points compared to Q2 2024 – Earnings per share for the second quarter of 2025 were ($0.01), compared to ($0.21) in the year-ago period

BioXcel Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Updates GlobeNewswire August 12, 2025 Topline data from SERENITY At-Home Phase 3 trial for acute treatment of agitation associated with bipolar disorders or schizophrenia expected in August FDA meeting scheduled in August and is intended to support potential sNDA submission for label expansion of

NEW YORK, NY / ACCESS Newswire / August 12, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding Hims & Hers Health, Inc. (NYSE:HIMS) class action securities lawsuit A Class Action lawsuit was filed on behalf of Hims & Hers Health, Inc. investors who lost money as a result of alleged securities fraud between

NEW YORK, NY / ACCESS Newswire / August 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Align Technology, Inc. ("Align Technology, Inc.") (NASDAQ:ALGN) concerning possible violations of federal securities laws. Align Technology, Inc. disclosed its financial results for the second quarter of 2025 on July 29, 2025, and

(OTCQB:ZAPPF),(OTC US:ZAPPF), LONDON, Aug. 12, 2025 (GLOBE NEWSWIRE) — Zapp Electric Vehicles Group Limited (OTCQB: ZAPPF) (“Zapp EV” or the “Company”), owner of “Zapp”, the British electric vehicle brand on a mission to electrify personal urban mobility, today announced a strategic retail partnership with Smartech Retail Group Limited (“Smartech”), the experiential technology specialist operating inside

NEW YORK, NY / ACCESS Newswire / August 12, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding 3D Systems Corporation (NYSE:DDD) class action securities lawsuit A Class Action lawsuit was filed on behalf of 3D Systems Corporation investors who lost money as a result of alleged securities fraud between August 13, 2024 and